Yook JH - Search Results

1

Efficacy of screening for gastric cancer in a Korean adult population: a case-control study.

Kim YS, Park HA, Kim BS, Yook JH, Lee MS. Kim YS, et al. Among authors: yook jh. J Korean Med Sci. 2000 Oct;15(5):510-5. doi: 10.3346/jkms.2000.15.5.510. J Korean Med Sci. 2000. PMID: 11068986 Free PMC article. Clinical Trial.

2

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.

Kim TW, Kang YK, Ahn JH, Chang HM, Yook JH, Oh ST, Kim BS, Lee JS. Kim TW, et al. Among authors: yook jh. Ann Oncol. 2002 Dec;13(12):1893-8. doi: 10.1093/annonc/mdf323. Ann Oncol. 2002. PMID: 12453857 Free article. Clinical Trial.

3

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.

Kang HJ, Chang HM, Kim TW, Ryu MH, Sohn HJ, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Kang HJ, et al. Among authors: yook jh. Br J Cancer. 2005 Jan 31;92(2):246-51. doi: 10.1038/sj.bjc.6602336. Br J Cancer. 2005. PMID: 15655540 Free PMC article. Clinical Trial.

4

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.

Kang HJ, Chang HM, Kim TW, Ryu MH, Sohn HJ, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Kang HJ, et al. Among authors: yook jh. Br J Cancer. 2008 Jan 29;98(2):316-22. doi: 10.1038/sj.bjc.6604186. Epub 2008 Jan 22. Br J Cancer. 2008. PMID: 18219288 Free PMC article. Clinical Trial.

5

Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.

Lee IS, Yook JH, Kim TH, Kim HS, Kim KC, Oh ST, Kim BS. Lee IS, et al. Among authors: yook jh. Eur J Surg Oncol. 2013 Feb;39(2):136-40. doi: 10.1016/j.ejso.2012.10.008. Epub 2012 Nov 11. Eur J Surg Oncol. 2013. PMID: 23148932

6

Suitability of endoscopic submucosal dissection for treatment of submucosal gastric cancers.

Lee IS, Yook JH, Park YS, Kim KC, Oh ST, Kim BS. Lee IS, et al. Among authors: yook jh. Br J Surg. 2013 Apr;100(5):668-73. doi: 10.1002/bjs.9051. Epub 2013 Jan 18. Br J Surg. 2013. PMID: 23334982

7

Impact of extranodal extension on prognosis in lymph node-positive gastric cancer.

Lee IS, Park YS, Ryu MH, Song MJ, Yook JH, Oh ST, Kim BS. Lee IS, et al. Among authors: yook jh. Br J Surg. 2014 Nov;101(12):1576-84. doi: 10.1002/bjs.9640. Epub 2014 Sep 16. Br J Surg. 2014. PMID: 25223244

8

Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.

Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK. Koo DH, et al. Among authors: yook jh. Eur J Surg Oncol. 2007 Sep;33(7):843-8. doi: 10.1016/j.ejso.2006.11.030. Epub 2007 Jan 5. Eur J Surg Oncol. 2007. PMID: 17207959

9

Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Cheong O, Oh ST, Kim BS, Yook JH, Kim JH, Im JT, Park GC. Cheong O, et al. Among authors: yook jh. World J Surg. 2008 Feb;32(2):262-6. doi: 10.1007/s00268-007-9158-4. World J Surg. 2008. PMID: 18064519

10

Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification.

Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, Choi KD, Jung HY, Kim JH, Yook JH, Kim BS, Jang SJ. Chung JW, et al. Among authors: yook jh. Dis Esophagus. 2009;22(8):676-81. doi: 10.1111/j.1442-2050.2009.00946.x. Epub 2009 Feb 13. Dis Esophagus. 2009. PMID: 19222529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters